RUCONEST (C1 Esterase - Inhibitor (Recombinant)‎)

Ruconest – Hereditary Angioedema leads to the swelling of extreme body parts. Ruconest is the first FDA-approved recombinant C1 esterase inhibitor (C1-INH), plasma-free drug for the treatment of HAE.

Salix and Pharming Announce FDA Approval of RUCONEST® for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE)

Ruconest for Treatment of Hereditary Angioedema (HAE)

US Hereditary Angioedema Association – HAEA

8080 Ravines Edge Court Columbus, Ohio 43235